Delivery Order SPE2DB22D3501-SPE2DB26FTE70
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nateglinide 120 mg tablets in quantities of 100 on August 5, 2025, with completion targeted for August 6, 2025. This competitively awarded, non-set-aside contract carries a ceiling value of $1,573.16 and operates under firm fixed price terms. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as both the place of performance and the awardee location....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,475.49 to AmerisourceBergen Drug Corp for the supply of Nateglinide 60 mg tablets (100-count units) under a firm fixed price contract. The award was issued on June 26, 2025, with an ultimate completion date of June 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award represents a routine pharmaceutical procurement action within the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Nateglinide 60 mg tablets (100-count units) with a ceiling value of $1,554.62. This firm fixed-price delivery order, which has a completion date of September 10, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's leading pharmaceutical distributors and serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $10,181.29 to AmerisourceBergen Drug Corp for the supply of Nateglinide 60 mg tablets (100-count units) with an ultimate completion date of August 19, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency awarded a delivery order valued at $2,919.52 to AmerisourceBergen Drug Corp for the supply of Nateglinide 120 mg tablets (100-count units) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Nateglinide is a rapid-acting insulin secretagogue used in diabetes management,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,079.18 to supply Nateglinide 120 mg tablets (100-count units) under a firm fixed price contract with an ultimate completion date of July 29, 2025. This non-set-aside award was competitively procured and represents a child contract action originating from AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,694.90 to AmerisourceBergen Drug Corp for 100 tablets of Nateglinide 60 mg, an oral antidiabetic medication. This competitive, non-set-aside delivery order, effective through September 18, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location under firm fixed price terms. The award represents a child contract action under AmerisourceBergen Drug Corp's larger indefinite delivery contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Nateglinide 60 mg tablets in quantities of 100 units, with a contract ceiling value of $6,925.84 and a firm fixed price structure. This delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of September 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Nateglinide is...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nateglinide 60 mg tablets. The contract has a ceiling value of $4,166.99 and runs through April 2, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,634.67 firm-fixed-price contract is for the delivery of Nateglinide 60 mg tablets, a type of oral antidiabetic medication. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTE70Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,518.65 to AmerisourceBergen Drug Corp for the supply of Nateglinide 60 mg tablets (100-count units) on October 21, 2025, with an ultimate completion date of October 22, 2025. This non-set-aside contract employs firm fixed pricing under a delivery order contract type and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting the federal medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare systems globally. As a major pharmaceutical distributor, AmerisourceBergen regularly fulfills competitively awarded federal procurement requirements for medications spanning multiple therapeutic domains, serving defense and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 10/21/25 |